Study Stopped
Not possible to recruit
Detection of Bacteria in Herniated Nucleus Material in Lumbar Disc Herniations by Culture and PCR
1 other identifier
observational
5
1 country
1
Brief Summary
The aim is to investigate if herniated nucleus material in lumbar disc herniations is infected with bacteria, and if so, to determine their prevalence (control group), and to determine if patients with pre-existing Modic changes type 1 have a higher incidence of bacterial growth in relevant lumbar disc samples than patients without Modic changes. A cohort of 15 patients with pre-existing Modic and 15 without-undergoing primary surgery will be examined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 4, 2015
CompletedFirst Posted
Study publicly available on registry
March 11, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedJuly 30, 2024
July 1, 2024
1 year
March 4, 2015
July 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bacterial growth on a per-patient basis
at time of surgery
Eligibility Criteria
Patient with MRI-confirmed lumbar disc herniation. Lumbar disc herniation. Age between 18 and 65 years. No prior spine surgery. No diagnosed dementia.
You may qualify if:
- MRI-confirmed lumbar disc herniation.
- Age between 18 and 65 years.
- No prior spine surgery.
- No diagnosed dementia.
You may not qualify if:
- Antibiotic treatment within the previous two weeks.
- History of alcohol abuse, illicit drug use or drug abuse, or significant mental illness
- Known immune deficiency state (e.g., positive for human immunodeficiency virus) or in treatment with immunosuppressive drugs including high dose steroids or cyclosporine.
- Concurrent infections (infections of skin, urinary tract infection, other skin diseases, e.g. Acne vulgaris).
- Previous epidural instrumentation.
- Uncontrolled, unstable or recently diagnosed autoimmune disease, including but not limited to systemic lupus erythematosus, inflammatory bowel disease, sarcoidosis, rheumatoid arthritis, or psoriasis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Spine Centre of Southern Denmarklead
- Vejle Hospitalcollaborator
Study Sites (1)
Middelfart Spinesurgery research department
Middelfart, Region Syddanmark, 5500, Denmark
Biospecimen
Biopsies of Nucleus
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karen H. Hansen
Sygehus Lillebaelt
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research nurse
Study Record Dates
First Submitted
March 4, 2015
First Posted
March 11, 2015
Study Start
October 1, 2014
Primary Completion
October 1, 2015
Study Completion
October 1, 2016
Last Updated
July 30, 2024
Record last verified: 2024-07